chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very red, tender to touch, swollen within 4-5 hours symptoms started. Dimensions 1 1/2 x 2 3/8  on right leg.
Received vaccine following temperature excursion; Received vaccine following temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Received vaccine following temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received vaccine following temperature excursion) in a 35-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Received vaccine following temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received vaccine following temperature excursion). On 18-Mar-2021, PRODUCT TEMPERATURE EXCURSION ISSUE (Received vaccine following temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Received vaccine following temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  No treatment information was reported.
allergic reaction; feel overall achy; overall Weariness; lack of appetite; heat in my cheek and jawline of the same side of the injection; bitter taste; tongue becoming slightly numb; prickling feeling in my throat; injection site sore; injection site swollen; This case was reported by a consumer via call center representative and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th August 2019, the patient received the 1st dose of Shingrix. In August 2019, less than a week after receiving Shingrix, the patient experienced injection site pain and injection site swelling. On 27th August 2019, the patient experienced feeling of warmth facial, taste bitter, numbness of tongue and throat irritation. On 28th August 2019, the patient experienced pain, weariness and appetite absent. On an unknown date, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction, feeling of warmth facial, taste bitter, numbness of tongue and throat irritation were recovered/resolved and the outcome of the injection site pain, injection site swelling, pain, weariness and appetite absent were unknown.   It was unknown if the reporter considered the allergic reaction, injection site pain, injection site swelling, feeling of warmth facial, taste bitter, numbness of tongue, throat irritation, pain, weariness and appetite absent to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. Within seconds of being injected with the vaccine before the date of reporting the patient experienced heat in my cheek and jawline of the same side of the injection, along with a bitter taste in my mouth, followed by the tip of my tongue becoming slightly numb and a prickling feeling in my throat. These symptoms slowly dissipated perhaps 2 minutes, though the attending nurse said 5 minutes. The patient doctor contends that it was too soon for it to have been an allergic reaction, yet has determined it best if I did not receive the 2nd required injection. The patient asked could the injection have hit a blood vessel and been directly injected into my blood stream rather than my muscle, thus resulting in the unusual symptoms and what type of effectiveness would there be against shingles since I would not be able to receive the second injection. At the time of reporting the patient feel overall achy and a complete feeling of overall weariness and lack of appetite. The injection site was very sore and swollen.
Pt reports noticing a rash on both sides of neck that also included itching all over. She said it started about 20 minutes after vaccine while in parking lot. She called us on her way home and clarified no shortness, of breath, wheezing, or itchy throat. I advised her to take Benadryl and have husband closely observe incase she has any respiratory symptoms and if she did to call 911 or head to the ER depending on severity. I followed up with her 30 minutes after she took the Benadryl and she was less itchy. I then called her at 7:30 pm and she said the rash was gone and almost all of the itching as well
PATIENT WAS PROFUSELY SWEATING IN HIS POST WAIT TIME AFTER VACCINE ADMINISTRATION. HE WAS WEARING A BEANIE AND HOODIE AND WAS ASKED TO REMOVE THOSE. ICE PACKS WERE APPLIED TO HIS WRISTS AND NECK AND HE FELT BETTER WITHIN A FEW MINUTES. INITIALLY HE STATED HE WAS A LITTLE DIZZY BUT UPON REMOVING HIS HOODIE THAT WENT AWAY. HIS BLOOD PRESSURE WAS NORMAL. HE FELT BETTER IN APPROX 5 MIN AND THE SWEATING STOPPED  WITHIN 5 MIN UPON REMOVAL OF EXCESS CLOTHING AND ICE PACKS.
the patient had two episodes of chest tightness; felt poorly after receiving Flu vaccine; flushing; Initial information received on 28-Oct-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.    This case involves a 55-year-old male patient who experienced had two episodes of chest tightness (chest discomfort), felt poorly after receiving flu vaccine (malaise) and flushing after receiving vaccine INFLUENZA VACCINE.  The patient's medical history included Pulmonary arterial hypertension.  Medical treatment, vaccination and family history were not provided.   Concomitant medications included TREPROSTINIL SODIUM (TYVASO) Inhalation Gas, 0.6 mg/ml.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  In OCT-2021, the patient developed a non-serious had two episodes of chest tightness (chest discomfort), felt poorly after receiving flu vaccine (malaise) and flushing (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the events.  At the time of reporting, the outcome of events was reported as unknown.  There will be no information available on the batch number for this case.
On an unknown date in Dec2020 / received the first Engerix-B / did not return / to receive the second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 55-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (1st dose received on December 2020, intramuscularly).   On an unknown date, the patient received the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Engerix B, which led to incomplete course of vaccination. The reporter consented to follow up.
Inconsolable crying, fever, father states pt having trouble breathing, shook, & stopped breathing; No medical treatment sought @ that time; F/U next day w/private MD;
9/26 Presented with SOB/dyspnea, hypoxic; Covid + ED; Admit 9/26 medical with Covid PNA; tx with 9/26 steroids, merrem, Vit C, lovenox, zinc; O2 requirements- 4 LPM at admission; to Room Air by d/c
In September 2021, I received my second dose of Pfizer covid 19 vaccine. 12/2021 I had an episode of acute pancreatitis where I experienced severe abdominal pain 10/10 2-3 days in a row for less than an hour. At ER, my lipase levels were in 599. CT of abdomen and pelvis was negative except for a hutch diverticuli on bladder which was found incidentally.   01/2022 I tested positive for Covid 19 with symptoms for the second time (the first time 12/2022). After the episode of acute pancreatitis, I continued to have abdominal discomfort, diarrhea, nausea, chills, and abnormal weight loss (190lbs December 2022 down to 165 August 2022). August 2022, diagnosed with exocrine pancreatic insufficiency. I've been eating healthy, exercising, and maintaining a healthy lifestyle up until this episode of pancreatitis. I had regular blood work done with my PCP and am a registered nurse myself.
No adverse event - pt was given DTaP and should have received Tdap.  CDC was called 3-13-08.
his bottom lip got big on the right side, like is gonna burst.; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (his bottom lip got big on the right side, like is gonna burst.) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Allergy (Unspecified.).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced LIP SWELLING (his bottom lip got big on the right side, like is gonna burst.). On 08-Feb-2021, LIP SWELLING (his bottom lip got big on the right side, like is gonna burst.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Diffuse body rash and facial swelling within first hour after injection. Rash resolved in 24 hours, with benadryl, facial swelling took 2-3 days. Mood swings and irritability also occurred, took a week to completely subside. No respiratory symptoms at any time per mom.
Initial report received from the nurse on 16 Dec 2009: It was reported that the 3 year old patient had received FLUVIRIN on 14 Dec 2009 which reported to be possible off level use. No further information reported at the time of the report.
A serious, spontaneous report on 14-month-old was "inadvertently given FluMist" lethargy, very ill and Influenza B has been received from a physician concerning a 14 month old female patient, subsequent to receiving FluMist. The patient's medical history and concomitant medications were not reported. The patient received FluMist on approximately 07-October-2009. The patient was inadvertently given FluMist. Subsequently, the patient became very ill. On 14-Oct-2008 the patient tested positive for Influenza B. As of 03-Nov-2009, the patient was still very ill and lethargic. On an unknown date, the patient was hospitalized. Encephalitis was ruled out and the reporter indicated they "still don't know what's going on with the patient". The events were ongoing.11/17 and 11/24/2009 ED records for 10/7-10/9 and 10/24-10/26/2009. Patient with c/o's fever , dehydration, decreased appetite and lethargy. Tx: IVF for rehydration. On 10/26 transferred to another facility for continued care. 11/30/2009 MR, DC summary for 10/26/2009-11/3/2009, patient with fever, diarrhea, change in mental status. Tx: LP,  IV ABX, Acyclovir, Tamiflu DC Dx: Dehydration, Viral encephalopathy, Septic shock Follow-up: 19FEB2010: per MI conventions, mnfr for other vaccines not collected.
Gave the 0.5ml for 3rd dose instead of 0.25ml.
99-100 degree fever for two days upset stomach, haven't eaten much since the shot, lost 3 pounds thus far fatigue, sleep 12-18 hrs a day sore throat, cough for two days tested negative twice for Covid 19
diagnosed with COVID/Fever, tiredness, cough; diagnosed with COVID/Fever, tiredness, cough; This is a spontaneous report from a contactable female consumer (patient). A 71-year-old female patient received first dose bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 05Mar2021 (Lot Number: EN6202) at single dose for COVID-19 immunisation.  Medical history included type 2 diabetes from 1995 to an unknown date. The patient's concomitant medications were not reported.  The patient was questioning the vaccine's efficacy because she had received her 1st dose last 05Mar2021 which was 7 and a half weeks ago. She mentioned that this was because 2 days before her supposed scheduled 2nd dose on 26Mar2021, she started running a temperature and suspected that she was infected by her Husband who had COVID at that time. She was diagnosed with COVID on 27Mar2021. She mentioned that she had a cough that would not go away so that was why she made sure that she had no symptoms before getting her 2nd shot. This past weekend, she mentioned that the cough was not as prevalent as before so she decided to get the shot. She mentioned that the nurse at the facility said that she would still be okay until she mentioned that her 1st shot was on 05Mar2021. She mentioned that her husband was healthier than her that's why he got the 2nd dose 6 and a half weeks after the 1st one. She would like to know if it will be still effective with her. She had been coughing and had a fever.  When asked to provide outcome for COVID virus, she stated that she was basically recovered, but was still a little tired.  At night time, she starts coughing.  She did fine during the day, but she was so much better.  She was able to do things.  She just has a little bit of a cough. This all started around 5 days into it.  Fever started 24Mar2021.  It lasted for 13 days and the last day of fever was 05Apr2021.   She started coughing 30Mar2021 or 31Mar2021. She later stated it may have been more like 28Mar2021 or 29Mar2021. She will be 72 on Sunday and said she was old and that just comes with being old. She felt ok.  The tiredness started time same time as the coughing.  She did not feel bad until she started coughing. A couple of days after she was diagnosed was when she started feeling bad.  She was able to drive herself to get the test and took a shower and felt ok.  She took the test on Friday and found out on Saturday.  On Sunday and Monday was when she started coughing.  That was when the fever started and it never got over 100.5 degrees. Adverse events (AE) details and time of onset was reported as: positive COVID virus in the morning; cough in the morning; fever in the afternoon; tiredness in the morning. There was no prescriber.  She just had it because she was a high risk patient. There were additional vaccines administered on same date of the Pfizer suspect, no prior vaccinations (within 4 weeks), AE following prior vaccination, family medical history and relevant test. The outcome of the events was recovering.
No adverse effects have been reported; only the bevel of the needle was inserted into the patient; This spontaneous report was received from a medical assistant and refers to a 12-month-old patient of unknown gender. No details regarding the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies were provided. On 08-MAY-2019, the patient was vaccinated with one dose of varicella virus vaccine live (oka/merck)(VARIVAX), subcutaneously, lot # R023737, expiration date  20-AUG-2020 (dose, strength and dose number were not reported) for prophylaxis. The dose was reconstituted with a sterile diluent. The needle was not inserted correctly during administration, only the bevel of the needle was inserted into the patient. No adverse effects were reported.
allergy to tetanus toxoide and vertioxetine; Initial information received on 18-May-2020 regarding an unsolicited valid non-serious courtesy case from a physician via non-licensed partner (pfizer).  This case involves a patient who experienced allergy to tetanus toxoide and vertioxetine (hyeprsensitivity), while he/she received vaccine TETANUS TOXOID and while treated with VORTIOXETINE.  The patient's medical history, past medical treatment, past vaccination and family history were not provided. Concomitant medication were not reported.   On an unknown date, the patient started taking VORTIOXETINE dosage unknown (with an unknown batch number) via unknown route for unknown indication. On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer (lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious allergy to tetanus toxoide and vertioxetine (hypersensitivity) (Unknown latency) following the first dose intake and (unknown latency) following the last dose intake of VORTIOXETINE and (Unknown latency) following the administration of TETANUS TOXOID.  Laboratory details were not reported.  Final diagnosis was hypersensitivity.  The action taken for VORTIOXETINE was unknown.  It was not reported if the patient received any corrective treatment.  The event outcome was not reported.  There will be no information available on batch number for this case.
Dizziness; hypertensive to 109/80; nauea, sweating, sent to ED for monitoring; follow up call next day: symptoms resolved.
Ache; Body temperature grew; After the three days of the first shot of vaccine, the was tested positive for COVID.cough; This is a spontaneous report from a contactable consumer (Family member). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EP6775), dose 1 via an unspecified route of administration, administered in arm left on 09Mar2021 12:30 as 1st dose, single for covid-19 immunisation. Medical history included colon cancer (Verbatim: Colon cancer, He was diagnosed a year ago of colon rectum cancer and thats it and he does not have another serious conditions, he reside the colon cancer, he saved it from the cancer things a year ago back so he got in to the stomach and into the vest) and ostomy (Verbatim: patient also has ostomy, so he was using like ostomy bag because he had a colon cancer). Concomitant medication included pregabalin (LYRICA). After the three days of first shot, patient was diagnosed with COVID. he experienced the test of COVID was the ache, cough, respiratory symptoms and body temperature grew. Patient went under treatment around three weeks in oxygen. The seriousness was reported as non-serious. Patient recovered from Covid wanted to know if this patient can get a second dose. The outcome of the event tested positive for COVID was recovered and for other it was unknown.   Lot/Batch no. available. Additional information has been requested.
Narrative:  Patient was admitted with severe COVID-19 requiring ICU admission after completing the full vaccine series > 2 weeks prior. Of note, patient does have CLL.
Within a week after receiving my 2nd dose, I started to experience PVC's. It seemed to have lasted about 2 weeks until they became regular again. My PA has informed me that I should not receive another booster since I have had cardiac issues after receiving my 2nd and 3rd dose. I am concerned about permanent damage down the road because of the heart issues.
30 minutes after vaccine heart rate increased to 130 BPM, tingling in extremities, lightheadedness, rapid breathing, and nasal congestion began. Patient was driving home from vaccine site when symptoms presented. Patient drove to nearest emergency room for assessment and treatment. Patient was placed on heart and blood pressure monitors. IV fluids were administered. EKG was administered. Heart rate decreased after about an hour. Patient stayed at the emergency room for roughly 2 hours before feeling well and being released.
Is it normal for your arm to swell a bit a couple days after getting; Hiw long will it take for my arm to stop being sore; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Is it normal for your arm to swell a bit a couple days after getting) and MYALGIA (Hiw long will it take for my arm to stop being sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Is it normal for your arm to swell a bit a couple days after getting) and MYALGIA (Hiw long will it take for my arm to stop being sore). At the time of the report, PERIPHERAL SWELLING (Is it normal for your arm to swell a bit a couple days after getting) and MYALGIA (Hiw long will it take for my arm to stop being sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.
5cm x 3 1/2cm erythema.  11cm x 10cm lighter erythema.  Warm to touch.  SQ - right upper arm.
Patient passed out within 45 seconds of vaccine, convulsed for 5 secs while unconscious. woke up with in a minute, vomited  after 3 minutes. He was able to say his name and address. BP 116/69 Pulse 68. patient said that this has happened before after an unknown booster at age 17.  Only ate french fries earlier today. Was able to stand after 5 minutes. Put cool paper towel on neck, ate fruit bar and drank water before leaving
Fever, tachypnea, diarrhea, nausea vomiting and chills. Ceftriaxone 2 gm once, ciprofloxacin 500 mg BID, sodium chloride 1000 ml once.
Pleurisy; Redness - Near Injection Site; Itchy Sensation - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PLEURISY (Pleurisy) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Pleurisy.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLEURISY (Pleurisy). At the time of the report, PLEURISY (Pleurisy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medication included steroid injections for pleurisy.
Mom noted redness, swelling and warmth of (R) upper arm starting 5/4/11 getting worse. 5/5/11 with itching of area also. Tx with BENADRYL 1 tsp QID.
Low grade fever within 24 hours after administration; mild rash at injection site (24-48 hours post-injection) manifesting to moderate rash after 48 hours (>4 inches in diameter).
On 6/24/2021 patient reports woke up in the AM went to apply eye makeup and right eye would not close. During the day had drooping right mouth w/drooling went to urgent care - Dx: Bell's Palsy at Urgent Care. prescribed Prednisone dosepak x 14 days and Valcyclovir tid x 7 days. She followed up on 6-29-2021 @ resident clinic@ Medical Center. Was prescribed Tobramycin for bacterial conjunctivitis. Followed up @ Primary Care on 7-29-2021 and reports complete resolution of symptoms.
cough, other covid symptoms (refused initial interview with LHD), monoclonal antibody treatment
FEVER 102F, Shortness of breath, oxygen saturation 77% on room air, shaking and chills, vomiting, weakness, elevated heart rate and elevated BP
Shortness of breath so acute I went to urgent care on 2/19. Received 2 inhalers, one a steroid and one Returning to doctor on 2/23   I also have dizziness that resulted in a fall. And itching under my right ribs. The whole reaction feels like an asthmatic allergic response.